FDA.reportPublic FDA data

MG217 Psoriasis

Manufacturer
Wisconsin Pharmacal Company
Effective date
2026-03-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:51:02

Label at a glance#

ProductMG217 Psoriasis Medicated multi-symptom
Active ingredientCOAL TAR
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient

Coal Tar 2% (from Coal Tar Topical Solution, USP 20%)

OTC - PURPOSE SECTION

Purpose

Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

INDICATIONS & USAGE SECTION

Uses For the relief of these symptoms associated with psoriasis and/or seborrheic dermatitis ■ itching ■ scaling
■ flaking ■ redness ■ irritation of the skin. Helps prevent recurrence.

WARNINGS SECTION

Warnings
For external use only. Use only as directed.

OTC - ASK DOCTOR SECTION

Ask a doctor before use ■ for prolonged periods ■ if condition covers a large area of the body ■ around the rectum or in the genital area or groin ■ with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs ■ do not use for prolonged periods without consulting a physician.

OTC - WHEN USING SECTION

When using this product ■ Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. ■ Not recommended for use on scalp unless directed by a physician, ointment may be difficult to remove from hair.

OTC - STOP USE SECTION

Stop use and ask a doctor if ■ condition worsens ■ condition does not improve after regular use of this product as directed. Use caution in exposing skin to sunlight after applying this product, as it may increase your tendency to sunburn for up to 24 hours after application.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

OTHER SAFETY INFORMATION

WARNING: This product can expose you to chemicals including Coal Tar, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov

DOSAGE & ADMINISTRATION SECTION

Directions
Apply to affected areas 1 to 4 times daily or as directed by a physician.

INACTIVE INGREDIENT SECTION

Inactive ingredients
Petrolatum, C12-15 Alkyl Benzoate, Bis-Diglyceryl Polyacyladipate-2, PEG/PPG-18/18 Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Vitamin E Acetate, Vitamin A (retinyl palmitate), Vitamin D 3 (cholecalciferol)

OTC - QUESTIONS SECTION

Questions or comments? 1-800-635-3696

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Multi-symptom Coal Tar Ointment for Psoriasis and Seborrheic DermatitisMulti-symptom Coal Tar Ointment for Psoriasis and Seborrheic Dermatitis

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68093-7233-1MG217 PsoriasisMedicated multi-symptom1 in 1 CARTONOINTMENT12
68093-7233-1MG217 PsoriasisMedicated multi-symptom107 g in 1 JAROINTMENT1072

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68093-723368093-7233-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
NameUNIIKind
CHOLECALCIFEROL1C6V77QF41IACT
PETROLATUM4T6H12BN9UIACT
.ALPHA.-TOCOPHEROL, D-N9PR3490H9IACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
COAL TARR533ESO2ECACTIB
ALKYL (C12-15) BENZOATEA9EJ3J61HQIACT
PEG/PPG-18/18 DIMETHICONE9H0AO7T794IACT
PEG-100 STEARATEYD01N1999RIACT
VITAMIN A PALMITATE1D1K0N0VVCIACT
BIS-DIGLYCERYL POLYACYLADIPATE-26L246LAM9TIACT

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MG217 Psoriasis Medicated multi-symptomCOAL TARWisconsin Pharmacal Company7cb04d20-9b3c-27bb-e053-2a91aa0a5bc42026-03-20WarningsExact identifier
ndc (package): 68093-7233-1
ndc (product): 68093-7233
ndc11 (package): 68093723301
spl id: 4d798735-b284-5c64-e063-6394a90ac72d
spl set id: 7cb04d20-9b3c-27bb-e053-2a91aa0a5bc4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.